Results 51 to 60 of about 59,240 (301)
An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK?
Medical Cannabis and Cannabinoids, 2020 This paper evaluates current regulatory regimes of medical cannabis using peer-reviewed and grey literature as well as personal communications. Despite the legalization of medical cannabis in the UK in November 2018, patients still lack access
Anne Katrin Schlag
doaj +1 more source
Brain and Behavior, 2023 Introduction : There are limited therapeutic options for individuals with fibromyalgia. The aim of this study is to analyze changes in health‐related quality of life and incidence of adverse events of those prescribed cannabis‐based medicinal products ...
Claire Wang +10 more
doaj +1 more source
IPU: Medical cannabis update. [PDF]
, 2019 In this article, Pamela Logan, Director of Pharmacy Services, IPU, gives an update on access to medical cannabis in Ireland. Licence for cannabis In Ireland Cannabis is classified as a Controlled Drug, Schedule 1 (with a few exceptions), which means
Logan, Pamela
core
Breaking point: Identifying the factors that predict suspension from school
British Educational Research Journal, EarlyView.Abstract School suspensions are associated with adverse educational and psychosocial outcomes, yet little is known about how structural disadvantage, relational factors, health behaviours, well‐being indicators and school‐level factors jointly predict suspension risk in England.
Stephanie Cahill +5 more
wiley +1 more source
Harm Reduction JournalBackground Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However, access to medical cannabis remains limited, particularly for underserved populations. To understand how patients experience medical
Eloise W. Freitag +7 more
doaj +1 more source
Preventive Medicine ReportsObjectives: We characterized trends in medical cannabis use; examined characteristics associated with medical cannabis use without medical authorization; and examined the association between recreational cannabis legalization and medical cannabis use in ...
Sameer Imtiaz +6 more
doaj +1 more source
Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report
Frontiers in Pharmacology, 2022 Cannabidiol (CBD) rich products are successfully used in some countries for treating symptoms associated with autism spectrum disorder (ASD). Yet, CBD provides insufficient intervention in some individuals, or for some characterizing symptoms of ASD ...
Noa Raz +5 more
doaj +1 more source
Medical cannabis – time for change [PDF]
, 2018 Cannabis has been used as a medicine for centuries but in recent history has been made illegal worldwide. Now the barriers to use are breaking down and over 40 countries have legalised the plant for medicinal use.
Mike Barnes
core +1 more source
Exposing Gender Blindness in Business Scholarship on Modern Slavery
Corporate Social Responsibility and Environmental Management, EarlyView.ABSTRACT The objective of this review is to analyse the treatment of gender within business scholarship on modern slavery and to propose a framework that supports more gender‐sensitive corporate responses. Modern slavery risk is an escalating concern for business, with the United Nations calling for its eradication by 2030.
Kathyayini Kathy Rao +2 more
wiley +1 more source
Maltese health and social wellbeing student knowledge, attitudes and beliefs about medical cannabis
Complementary Therapies in Medicine, 2021 Given the recent emergence of medical cannabis legalization in Malta, the objective of this study was to assess knowledge, attitudes, and beliefs about medical cannabis among a sample of Maltese students. The sample comprised 327 students enrolled in the
Jamie Bonnici, Marilyn Clark
doaj +1 more source